12 min listen
ACC CardiaCast: The Cardio-Protective Nature of DM Pharmacotherapies
FromACC CardiaCast
ratings:
Length:
10 minutes
Released:
Aug 17, 2018
Format:
Podcast episode
Description
This podcast discusses the article "Lower Cardiovascular Risk Associated with SGLT-2i in >400,000 Patients: The CVD-REAL 2 Study." The multinational study explores real world evidence on the use of sodium-glucose cotransporter-2. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
Released:
Aug 17, 2018
Format:
Podcast episode
Titles in the series (96)
ACC CardiaCast: Optimal Lipid Therapy: In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein... by ACC CardiaCast